Editing AUA: Upper Tract Urothelial Carcinoma (2023) (section)

==== Indications ====
* '''<span style="color:#ff0000">Preferred</span>''' 
**'''<span style="color:#ff0000">Initial management for LR favorable UTUC, when technically feasible</span>'''
***Observational studies suggest similar cancer-specific survival, similar complication rates, and improved renal function outcomes with endoscopic ablation, compared to nephroureterectomy
* '''<span style="color:#ff0000">Optional</span>''' 
**'''<span style="color:#ff0000">Initial management for LR unfavorable UTUC and select patients with HR favorable disease who have low-volume tumors or cannot undergo RNU</span>'''
*'''<span style="color:#ff0000">If low-risk and complete endoscopic ablation not feasible, chemoablation (in-situ tissue destruction) with mitomycin containing reverse thermal gel can be a treatment alternative</span>'''
**High risk of ureteric stenosis with instillation of mitomycin containing reverse thermal gel